Page last updated: 2024-11-08

pentylenetetrazole and Diaphragmatic Paralysis

pentylenetetrazole has been researched along with Diaphragmatic Paralysis in 2 studies

Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SAKAI, F1
DAL RI, H1
ERDMANN, WD1
SCHMIDT, G1
Nishie, K1
Waiss, AC1
Keyl, AC1

Other Studies

2 other studies available for pentylenetetrazole and Diaphragmatic Paralysis

ArticleYear
[Respiratory paralysis by parathion or paraoxon and antagonistic influences].
    Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie, 1958, Volume: 234, Issue:3

    Topics: Autonomic Agents; Humans; Hydroxylamines; Paraoxon; Parathion; Pentylenetetrazole; Pyridines; Respir

1958
Toxicity of methylimidazoles.
    Toxicology and applied pharmacology, 1969, Volume: 14, Issue:2

    Topics: Animals; Anticonvulsants; Chickens; Chlordiazepoxide; Electroencephalography; Heart Rate; Imidazoles

1969